Young EORTC Fellow presents her work at ECP 2017 in Amsterdam
Maria Urbanowicz, a young pathology fellow at the EORTC, presented [...]
EORTC at ESMO 2017 in Madrid
EORTC, in collaboration with ESMO and EACR, will present a [...]
Interim Results of the CATNON Study – the Effects of Temozolomide
The results of the interim analysis of the CATNON study [...]
Metastasis-Free Survival as a Strong Surrogate of Overall Survival in Localized Prostate Cancer
The results of an academic research project to which EORTC [...]
Diverging EU Health Regulations – Urgent Need for Harmonization
Recently, an article has been published in the Journal of [...]
Safeguarding the Future of Independent Academic Clinical Cancer Research – CAREFOR reaches out to the EU
An article being published in the ESMO Open provides a [...]
ESMO 2017 Congress: Tumours with rare oncogenic lesions – From pre-clinical to clinical validation
The European Organisation for Research and Treatment of Cancer (EORTC) [...]
Results from EORTC’s MINDACT Study Addressed in ASCO’s Breast Cancer Guideline Focused Update
The American Society of Clinical Oncology (ASCO) Clinical Practice Guidelines [...]
First european biomarker driven umbrella trial in recurrent / metastatic squamous cell carcinoma of the head & neck
L’Institut Roi Albert II des Cliniques Universitaires Saint-Luc (UCL) and [...]
EORTC Presentations at ASCO 2017 in Chicago
EORTC will be presenting one oral abstract session, three abstracts [...]
